CoChat

Changes in Prescription Drug Use After Gastric Bypass Surgery: A Nationwide Cohort Study

The DOI matches its Crossref record; 39 of the 40 references it cites were found in a registry or an index.

Abstract

OBJECTIVES: To evaluate changes over time in drug use among patients undergoing Roux-en-Y gastric bypass (RYGB) surgery and a matched population-based comparison cohort. BACKGROUND: A little is known about the prescription drug use before and after RYGB surgery. METHODS: Nationwide population-based cohort study included 9908 patients undergoing RYGB in Denmark during 2006 to 2010 and 99,080 matched general population members. We calculated prevalence ratios (PRs) comparing prescription drug use 36 months after RYGB/index date with use 6 months before this date (baseline). RESULTS: At baseline, more RYGB patients (median 40 years, 22% males) used a prescription drug (81.5% vs 49.1%). After 3 years, the use had decreased slightly among RYGB patients [PR = 0.93; 95% confidence interval (CI) = (0.91, 0.94)], but increased in the comparison cohort (PR = 1.05; 95% CI = 1.04-1.06). In the RYGB cohort, large, sustained decreases occurred for treatment of metabolic syndrome-related conditions, such as any glucose-lowering drug (PR = 0.28; 95% CI = 0.25-0.31) and lipid-modifying drugs PR = 0.50; 95% CI = 0.46-0.55). Use of inhalants for obstructive airway diseases (PR = 0.79; 95% CI = 0.74-0.85) also decreased. Use of neuropsychiatric drugs was two-fold higher at baseline in the RYGB cohort (22.8% vs 10.9%) and increased further after RYGB-that is, antidepressants (PR = 1.13; 95% CI = 1.07-1.19), antipsychotics (PR = 1.39; 95% CI = 1.21-1.60), and potential treatment of neuropathy (PR = 1.39; 95% CI = 1.28-1.51). CONCLUSIONS: Three years after RYGB surgery, we found large reductions in the use of treatment of metabolic syndrome-related conditions, inhalants for obstructive airway diseases and glucocorticoid use. In contrast, frequent use of neuropsychiatric drugs further increased after RYGB.

Overview

Integrity signals

Registry

Crossref · 10.1097/sla.0000000000001730

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 39 references

Cited by

See all 17

Metadata

Authors
Gribsholt, S. B., Thomsen, R. W., Farkas, D. K., Sørensen, H. T., Richelsen, B., & Svensson, E.
Affiliations
Aarhus University Hospital (DK)
Venue
Annals of Surgery
Published
2017-04
Volume
265
Issue
4
Pages
757-765
ISSN
0003-4932 (ISSN-L)
OpenAlex
W2336691644
Cited by
17
References
40
Citations by year
2026: 1 · 2025: 1 · 2024: 2 · 2023: 2 · 2021: 3 · 2020: 2 · 2019: 1 · 2018: 3
FWCI
2.21
Type
journal article
Language
en
Open access
closed
Locations
  • Annals of Surgery (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Lundbeckfonden (R155-2014-2647)
  • Novo Nordisk Fonden (NNF13OC0007171, NNF14SA0015794, NNF14OC0011633)
Topics
  • Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
  • Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
  • Health Sciences › Medicine › Surgery › Body Contouring and Surgery
Keywords
Roux-en-Y gastric bypass, prescription drug use, metabolic syndrome, antidiabetic drugs, lipid-modifying drugs, inhalants, obstructive airway disease, neuropsychiatric drugs, antidepressants, antipsychotic drugs, neuropathy treatment, glucocorticoids, bariatric surgery outcomes, Denmark, prevalence ratio, postoperative follow-up
MeSH terms
Adaptation, Psychological, Adult, Age Factors, Denmark, Female, Follow-Up Studies, Humans, Male, Middle Aged, Obesity, Morbid, Drug Prescriptions, Retrospective Studies, Sex Factors, Cohort Studies, Gastric Bypass, Body Mass Index, Incidence, Confidence Intervals, Case-Control Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Changes in Prescription Drug Use After Gastric Bypass Surgery: A Nationwide Cohort Study. https://app.cochat.ai/papers/10.1097/sla.0000000000001730
The paper
Gribsholt, S. B., Thomsen, R. W., Farkas, D. K., Sørensen, H. T., Richelsen, B., & Svensson, E. (2017). Changes in Prescription Drug Use After Gastric Bypass Surgery: A Nationwide Cohort Study. Annals of Surgery. https://doi.org/10.1097/sla.0000000000001730

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.